ES531908A0 - Un procedimiento para la preparacion de nuevas indolonas. - Google Patents

Un procedimiento para la preparacion de nuevas indolonas.

Info

Publication number
ES531908A0
ES531908A0 ES531908A ES531908A ES531908A0 ES 531908 A0 ES531908 A0 ES 531908A0 ES 531908 A ES531908 A ES 531908A ES 531908 A ES531908 A ES 531908A ES 531908 A0 ES531908 A0 ES 531908A0
Authority
ES
Spain
Prior art keywords
indolones
phenyl
treatment
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531908A
Other languages
English (en)
Other versions
ES8505951A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES531908A0 publication Critical patent/ES531908A0/es
Publication of ES8505951A1 publication Critical patent/ES8505951A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES531908A 1982-09-20 1984-04-25 Un procedimiento para la preparacion de nuevas indolonas. Expired ES8505951A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/420,544 US4476307A (en) 1982-09-20 1982-09-20 Heteroylidene indolone compounds

Publications (2)

Publication Number Publication Date
ES531908A0 true ES531908A0 (es) 1985-06-01
ES8505951A1 ES8505951A1 (es) 1985-06-01

Family

ID=23666904

Family Applications (3)

Application Number Title Priority Date Filing Date
ES525737A Expired ES8503328A1 (es) 1982-09-20 1983-09-19 Un procedimiento para la preparacion de nuevas idolonas.
ES531907A Granted ES531907A0 (es) 1982-09-20 1984-04-25 Un procedimiento para la preparacion de nuevas indolonas.
ES531908A Expired ES8505951A1 (es) 1982-09-20 1984-04-25 Un procedimiento para la preparacion de nuevas indolonas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES525737A Expired ES8503328A1 (es) 1982-09-20 1983-09-19 Un procedimiento para la preparacion de nuevas idolonas.
ES531907A Granted ES531907A0 (es) 1982-09-20 1984-04-25 Un procedimiento para la preparacion de nuevas indolonas.

Country Status (24)

Country Link
US (1) US4476307A (es)
EP (1) EP0104860B1 (es)
JP (1) JPS5976058A (es)
KR (1) KR860001270B1 (es)
AT (1) ATE25972T1 (es)
AU (1) AU543115B2 (es)
CA (1) CA1194871A (es)
DD (1) DD213211A5 (es)
DE (1) DE3370325D1 (es)
DK (1) DK157010C (es)
ES (3) ES8503328A1 (es)
FI (1) FI77446C (es)
GR (1) GR79732B (es)
HU (1) HU189747B (es)
IE (1) IE55923B1 (es)
IL (1) IL69758A (es)
NO (1) NO161557C (es)
NZ (1) NZ205638A (es)
PH (1) PH18297A (es)
PL (3) PL141876B1 (es)
PT (1) PT77360B (es)
SU (1) SU1272983A3 (es)
YU (4) YU189283A (es)
ZA (1) ZA836933B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5128352A (en) * 1989-01-10 1992-07-07 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
US5078756A (en) * 1990-01-12 1992-01-07 Major Thomas O Apparatus and method for purification and recovery of refrigerant
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
US5760250A (en) * 1991-11-05 1998-06-02 Zeneca Limited Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor
DE19949209A1 (de) * 1999-10-13 2001-04-19 Boehringer Ingelheim Pharma In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
WO2003027102A1 (en) * 2001-09-27 2003-04-03 Allergan, Inc. 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
US20050101788A1 (en) * 2002-03-27 2005-05-12 Jacopo Zanon Method for manufacture of sertindole
FR2847811B1 (fr) * 2002-11-29 2005-01-07 Oreal Composition filtrante contenant au moins un derive du dibenzoylmethane et au moins un derive de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one;procede de photostabilisation
FR2847813A1 (fr) * 2002-11-29 2004-06-04 Oreal Compositions cosmetiques photoprotectrices contenant des derives de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one et utilisations
ES2524922T3 (es) 2005-05-10 2014-12-15 Intermune, Inc. Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン， インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
WO2010070910A1 (ja) 2008-12-19 2010-06-24 日本曹達株式会社 1－ヘテロジエン誘導体および有害生物防除剤
BR112012011002B1 (pt) 2009-11-12 2019-06-25 Nippon Soda Company Limited Derivado de 1-heterodieno e agente de controle de pragas
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506683A (en) * 1963-10-07 1970-04-14 Upjohn Co 3-(2-pyrrolidinylidene)-3h-indoles
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
US3723457A (en) * 1969-09-30 1973-03-27 Eisai Co Ltd Indoline-2-one derivatives and preparation thereof
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
DE2557342A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NO833367L (no) 1984-03-21
FI77446B (fi) 1988-11-30
FI833335A0 (fi) 1983-09-19
SU1272983A3 (ru) 1986-11-23
FI77446C (fi) 1989-03-10
DE3370325D1 (en) 1987-04-23
IL69758A0 (en) 1983-12-30
IE832193L (en) 1984-03-20
PL141609B1 (en) 1987-08-31
ZA836933B (en) 1985-05-29
CA1194871A (en) 1985-10-08
PL141876B1 (en) 1987-09-30
ATE25972T1 (de) 1987-04-15
ES8505950A1 (es) 1985-06-01
KR840006239A (ko) 1984-11-22
NO161557C (no) 1989-08-30
PL141370B1 (en) 1987-07-31
YU169386A (en) 1987-10-31
IE55923B1 (en) 1991-02-27
DD213211A5 (de) 1984-09-05
ES525737A0 (es) 1985-02-16
YU189283A (en) 1987-10-31
DK157010C (da) 1990-03-26
DK425383D0 (da) 1983-09-19
PL250769A1 (en) 1985-07-02
JPS5976058A (ja) 1984-04-28
ES8505951A1 (es) 1985-06-01
IL69758A (en) 1986-12-31
NO161557B (no) 1989-05-22
PH18297A (en) 1985-05-24
EP0104860A1 (en) 1984-04-04
PT77360A (en) 1983-10-01
YU169286A (en) 1987-10-31
PT77360B (en) 1986-05-19
EP0104860B1 (en) 1987-03-18
FI833335A7 (fi) 1984-03-21
AU543115B2 (en) 1985-04-04
US4476307A (en) 1984-10-09
GR79732B (es) 1984-10-31
JPS6241711B2 (es) 1987-09-04
ES531907A0 (es) 1985-06-01
AU1925283A (en) 1984-03-29
NZ205638A (en) 1986-12-05
PL250768A1 (en) 1985-07-02
YU169186A (en) 1987-10-31
HU189747B (en) 1986-07-28
DK425383A (da) 1984-05-03
KR860001270B1 (ko) 1986-09-04
PL243826A1 (en) 1985-04-24
DK157010B (da) 1989-10-30
ES8503328A1 (es) 1985-02-16

Similar Documents

Publication Publication Date Title
ES531908A0 (es) Un procedimiento para la preparacion de nuevas indolonas.
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
ES2126122T3 (es) Nitrato-aminoacido-disulfuros para la terapia de enfermedades del sistema cardio-circulatorio.
LV11894A (lv) Jauni hromana un tiohromana atvasinajumi
DE69033703D1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
NO853698L (no) I-substituerte tetralinderivater, fremstilling og anvendel se derav.
ES545155A0 (es) Procedimiento para la obtencion de (pirrol-1-il)-fenil-dihi-dropiridazinona
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
ES538403A0 (es) Procedimiento para la obtencion de antipodas opticos del (+7-1,7-difenil-3-metilaza-7-ciano-8-metil-nonano
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
AR010304A1 (es) Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica
ES504751A0 (es) Un procedimiento para la preparacion de 4-alcohilo inferior-3-fenoxipiridina-1-oxido

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401